Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis.
about
CCR5 monoclonal antibodies for HIV-1 therapyRantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cellsThe GABAB receptor interacts directly with the related transcription factors CREB2 and ATFxAnalysis of ligand-stimulated CC chemokine receptor 5 (CCR5) phosphorylation in intact cells using phosphosite-specific antibodiesVaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replicationMultiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.CCL3, acting via the chemokine receptor CCR5, leads to independent activation of Janus kinase 2 (JAK2) and Gi proteins.The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways.N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopesChemokine receptor oligomerization and allostery.Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTESSlit proteins, potential endogenous modulators of inflammation.HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.The attraction of chemokines as a target for specific anti-inflammatory therapy.Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemiaCCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation.Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway.Mechanisms regulating chemokine receptor activity.HIV-1 Entry, Inhibitors, and ResistanceMechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.Endocytosis and recycling of the HIV coreceptor CCR5Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration.Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversityRho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors.Human cytomegalovirus chemokine receptor US28-induced smooth muscle cell migration is mediated by focal adhesion kinase and Src.Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor.Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine.The role of the human Duffy antigen receptor for chemokines in malaria susceptibility: current opinions and future treatment prospects.Aggregation-independent modulation of proteoglycan binding by neutralization of C-terminal acidic residues in the chemokine macrophage inflammatory protein 1alpha.Agonist-independent desensitization and internalization of the human platelet-activating factor receptor by coumermycin-gyrase B-induced dimerization.Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.Use of Resonance Energy Transfer Techniques for In Vivo Detection of Chemokine Receptor Oligomerization.Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes
P2860
Q22242739-802F5D52-A311-45AE-A814-7495105660FDQ24291028-B740D314-4171-4D7E-BABA-766DDE32C7AEQ24673707-E2FA08A8-FCFA-4901-8DDD-2E5BBD67CE9AQ28572119-BABA44B0-DFB6-461B-8B49-1D2DB084AC8CQ30540518-70AD632F-B16C-421D-8E67-9082C28E633DQ30857101-039A58C1-C53A-43F9-93CF-0D7261D1EA62Q33292191-32AD6D44-1BD3-426B-988F-2FE87574EAF4Q33412361-B999B6CB-0277-4834-A2E3-B65472A6D297Q33804016-41533E83-F09B-47A2-826A-1476BD7CC1EAQ33807693-8FF522DD-5CA6-4E0B-B29E-7C36879D6FE6Q33810517-264F9CF7-52B3-488B-A088-B6C1982413A0Q34079612-954CB883-1158-43D7-A8FA-359D06A3E56AQ34823587-19402D79-4640-4095-9A62-8F1798D1B60CQ35022576-EFF5C6B2-60B0-484F-ADD7-28F78C3EA756Q35110857-A976F53C-80E5-42EC-99ED-4E867AF4534AQ35566614-8F30A265-511A-4218-85A2-4B7404B0936BQ35749650-41B971A3-05E6-470D-A199-F5A4913E1F8CQ36028163-98B719FF-3364-4098-B30E-47E0F82586C0Q36370854-14EEFDD3-0C2F-4CE6-8446-990F2A1A86B6Q36402572-B5A533DF-DB92-42A5-8C9D-267BB21F3149Q36559608-E123644B-4304-4821-83BA-B303C6750693Q37177226-50CD6476-7A1D-4B0B-8A5F-8985522445A1Q37942973-EFD4E3FF-6071-48D2-A59F-D1D0154E2E14Q37945205-07FC0BFE-EB19-44A7-B249-72C5D908CF47Q39216644-5FDE4CC0-26E5-4259-A7E9-097A40FBDCCEQ39461957-BFB267C3-8E12-4A94-8563-10A2E64D13D9Q39556857-B2E7BC0F-CEEB-445F-B51A-5B1201155CB9Q39592527-97A402D3-3B63-48ED-B9FB-9B92DE26F1AFQ39700439-DAD93E91-A77B-4227-B731-5998875722A9Q40631906-BAF22E02-3066-42C4-B3B0-48D763B39127Q40774825-3FC2D635-FD35-4882-8C87-0E6E4C301152Q40795533-871B774E-C0C5-4811-B9F1-7DBBF90993FCQ41707671-F9944FDC-C30B-43F6-8F48-AE18FBDF78A9Q41812470-497FC2A5-E3CA-4A96-8707-1413DB23B184Q44447205-FD9D764D-7C0E-4462-8539-BD5F6C6C49DEQ45930874-589E7500-308C-4A2B-9320-D0DB4874EF4BQ51715586-F8D8619D-6FA5-4257-AAFD-943DB8A0E5FFQ56968947-9C964DA3-6CE0-45E2-BEE9-D3D12051134A
P2860
Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Similarities and differences i ...... : implications for chemotaxis.
@en
type
label
Similarities and differences i ...... : implications for chemotaxis.
@en
prefLabel
Similarities and differences i ...... : implications for chemotaxis.
@en
P2093
P2860
P356
P1476
Similarities and differences i ...... : implications for chemotaxis.
@en
P2093
A E Proudfoot
A J Vila-Coro
C Martínez-A
J M Rodríguez-Frade
P2860
P304
P356
10.1083/JCB.144.4.755
P407
P577
1999-02-01T00:00:00Z